No abstract available
MeSH terms
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Cardiac Pacing, Artificial
-
Cardiography, Impedance
-
Cardiomyopathy, Dilated / physiopathology
-
Chronic Disease
-
Clinical Trials as Topic
-
Comorbidity
-
Disease Management
-
Enoximone / therapeutic use
-
Heart Failure / drug therapy
-
Heart Failure / epidemiology
-
Heart Failure / physiopathology
-
Heart Failure / surgery
-
Heart Failure / therapy*
-
Hemodynamics
-
Humans
-
Kidney Diseases / chemically induced
-
Natriuretic Peptide, Brain / adverse effects
-
Natriuretic Peptide, Brain / therapeutic use
-
Natriuretic Peptides / physiology
-
Nitric Oxide / physiology
-
Nitric Oxide Synthase / antagonists & inhibitors
-
Pacemaker, Artificial
-
Phosphodiesterase Inhibitors / therapeutic use
-
Practice Guidelines as Topic
-
Xanthine Oxidase / antagonists & inhibitors
Substances
-
Angiotensin Receptor Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Natriuretic Peptides
-
Phosphodiesterase Inhibitors
-
Natriuretic Peptide, Brain
-
Nitric Oxide
-
Enoximone
-
Nitric Oxide Synthase
-
Xanthine Oxidase